Countries aren’t recruiting enough AI workers – OECD
Only a few countries are building the workforce needed to develop and run artificial intelligence (AI) in health applications, according to the Organisation for Economic…
Valneva shores up balance sheet after mixed trial results
Vaccine specialist Valneva has sold new shares worth €84 million as it moves to strengthen its balance sheet in the wake of mixed results for…
Novartis’ malaria drug for newborns cleared by WHO
The first malaria drug has received WHO prequalification for newborns
Outbreaks top AI concern – priority-setting report
Monitoring and preparing for disease outbreaks should be the top consideration for AI developers in global health, the first-ever global priority-setting report has concluded. The…
Real-time data on global dengue outbreaks
A global information service launched last week gives a real time snapshot of global dengue outbreaks across 88 countries. The Global Dengue Observatory, developed by…
Davos brain health plan hopes to unlock Africa funds
A brain health plan for Africa hopes to unlock funding by framing it within existing priorities such as maternal and child health, lifestyle-related diseases and…
GSK’s Q3 results buoyed by long-acting HIV jab
Strong performance in its long-acting HIV preventable has helped GlaxoSmithKline to raise its profit forecasts, with five new long-acting product launches now expected by 2030….
South Africa to make Gilead’s lenacapavir a ‘public good’
South Africa’s Minister of Health said the country plans to make Gilead’s twice-yearly HIV preventative lenacapavir into a “public good”, adding it would be “affordable…
Sanofi Global Health Unit says 1 mln reached since 2021
French drugmaker Sanofi says 1 million patients have received treatments for non-communicable diseases (NCDs) since 2021, thanks to its Global Health Unit. The update came…
Viiv/GSK pledge $8 mln ahead of Global Fund summit
GSK and HIV specialist ViiV Healthcare have pledged $8 million to the Global Fund, representing the biggest commitment to date from a private sector company…